Tibet Weixinkang Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	256.54	212.22	216.44	269.43	519.32	243.77
Trading Asset Securities	796	770	803	625.32	287	467.78
Cash & Short-Term Investments	1,053	982.22	1,019	894.75	806.32	711.55
Cash Growth	0.06%	-3.65%	13.94%	10.97%	13.32%	23.64%
Accounts Receivable	153.88	134.87	172.29	179.77	222.85	193.13
Other Receivables	2.37	2.17	1.93	2.2	2.14	1.22
Receivables	156.25	137.04	174.22	181.96	224.99	194.35
Inventory	58.04	59.82	41.96	38.34	32.54	22.68
Prepaid Expenses	-	-	2.62	1.73	1.68	2.14
Other Current Assets	99.7	109.84	77.14	83.12	73.43	78.44
Total Current Assets	1,367	1,289	1,315	1,200	1,139	1,009
Property, Plant & Equipment	415.32	416.46	380.25	361.21	333.73	324.14
Long-Term Investments	75.59	74.95	69.05	75.88	71.33	62.49
Other Intangible Assets	21.95	23.29	16.59	35.39	24.4	12.83
Long-Term Deferred Tax Assets	25.89	28.88	42.92	56.21	30.18	9.75
Long-Term Deferred Charges	31	15.73	16.91	26.36	41.52	73.35
Other Long-Term Assets	14.32	18.63	12.59	21.93	25.29	3.85
Total Assets	1,951	1,867	1,854	1,777	1,665	1,496
Accounts Payable	264.7	217.26	5.48	1.47	3.5	0.85
Accrued Expenses	11.43	50.45	314.28	269.95	284.17	271.98
Current Portion of Long-Term Debt	6.47	3.97	-	-	-	-
Current Portion of Leases	-	-	2.89	3.86	2.31	2.47
Current Income Taxes Payable	15.52	10.32	0.66	3.83	6.78	4.3
Current Unearned Revenue	3.22	6.39	7.24	4.4	6.54	7.75
Other Current Liabilities	64.07	59.93	96.63	111.27	108.5	131.92
Total Current Liabilities	365.42	348.31	427.18	394.79	411.8	419.26
Long-Term Leases	5.33	7.23	2.38	3.82	3.48	2.35
Long-Term Unearned Revenue	3.73	4.17	7.05	3.84	5.25	6.7
Long-Term Deferred Tax Liabilities	11.49	10.5	2.78	3.46	1.17	-
Other Long-Term Liabilities	20.32	20.27	28.86	30.64	23.14	-
Total Liabilities	406.29	390.49	468.24	436.55	444.84	428.31
Common Stock	435.16	435.16	435.16	435.16	435.16	435.92
Additional Paid-In Capital	347.64	347.64	347.64	347.15	341.35	318.64
Retained Earnings	791.1	722.76	631.28	579.63	453.82	346.51
Treasury Stock	-30	-30	-30	-22.37	-23.8	-52.88
Comprehensive Income & Other	0.41	0.8	1.36	0.78	14.05	19.07
Total Common Equity	1,544	1,476	1,385	1,340	1,221	1,067
Shareholders' Equity	1,544	1,476	1,385	1,340	1,221	1,067
Total Liabilities & Equity	1,951	1,867	1,854	1,777	1,665	1,496
Total Debt	11.81	11.2	5.27	7.68	5.79	4.81
Net Cash (Debt)	1,041	971.02	1,014	887.07	800.53	706.73
Net Cash Growth	-0.70%	-4.25%	14.33%	10.81%	13.27%	22.80%
Net Cash Per Share	2.41	2.25	2.35	2.07	1.85	1.69
Filing Date Shares Outstanding	427.12	435.57	432.33	435.16	435.16	435.92
Total Common Shares Outstanding	427.12	435.57	432.33	435.16	435.16	435.92
Working Capital	1,001	940.6	888.19	805.12	727.17	589.9
Book Value Per Share	3.62	3.39	3.20	3.08	2.80	2.45
Tangible Book Value	1,522	1,453	1,369	1,305	1,196	1,054
Tangible Book Value Per Share	3.56	3.34	3.17	3.00	2.75	2.42
Buildings	-	-	285.16	280.15	260.92	258.81
Machinery	-	-	297.15	274.57	236.19	215.29
Construction In Progress	-	-	37.98	15.19	17.11	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.